These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
269 related articles for article (PubMed ID: 12629192)
1. Norepinephrine in the prefrontal cortex is critical for amphetamine-induced reward and mesoaccumbens dopamine release. Ventura R; Cabib S; Alcaro A; Orsini C; Puglisi-Allegra S J Neurosci; 2003 Mar; 23(5):1879-85. PubMed ID: 12629192 [TBL] [Abstract][Full Text] [Related]
2. Prefrontal cortical norepinephrine release is critical for morphine-induced reward, reinstatement and dopamine release in the nucleus accumbens. Ventura R; Alcaro A; Puglisi-Allegra S Cereb Cortex; 2005 Dec; 15(12):1877-86. PubMed ID: 15728739 [TBL] [Abstract][Full Text] [Related]
3. Dopamine in the medial prefrontal cortex controls genotype-dependent effects of amphetamine on mesoaccumbens dopamine release and locomotion. Ventura R; Alcaro A; Cabib S; Conversi D; Mandolesi L; Puglisi-Allegra S Neuropsychopharmacology; 2004 Jan; 29(1):72-80. PubMed ID: 12968132 [TBL] [Abstract][Full Text] [Related]
4. Effects of dopamine depletion in the medial prefrontal cortex on the stress-induced increase in extracellular dopamine in the nucleus accumbens core and shell. King D; Zigmond MJ; Finlay JM Neuroscience; 1997 Mar; 77(1):141-53. PubMed ID: 9044382 [TBL] [Abstract][Full Text] [Related]
5. Parallel strain-dependent effect of amphetamine on locomotor activity and dopamine release in the nucleus accumbens: an in vivo study in mice. Zocchi A; Orsini C; Cabib S; Puglisi-Allegra S Neuroscience; 1998 Jan; 82(2):521-8. PubMed ID: 9466458 [TBL] [Abstract][Full Text] [Related]
6. In vivo evidence that genetic background controls impulse-dependent dopamine release induced by amphetamine in the nucleus accumbens. Ventura R; Alcaro A; Mandolesi L; Puglisi-Allegra S J Neurochem; 2004 Apr; 89(2):494-502. PubMed ID: 15056292 [TBL] [Abstract][Full Text] [Related]
7. Ethanol consumption and reward depend on norepinephrine in the prefrontal cortex. Ventura R; De Carolis D; Alcaro A; Puglisi-Allegra S Neuroreport; 2006 Nov; 17(17):1813-7. PubMed ID: 17164670 [TBL] [Abstract][Full Text] [Related]
8. Prefrontal/accumbal catecholamine system determines motivational salience attribution to both reward- and aversion-related stimuli. Ventura R; Morrone C; Puglisi-Allegra S Proc Natl Acad Sci U S A; 2007 Mar; 104(12):5181-6. PubMed ID: 17360372 [TBL] [Abstract][Full Text] [Related]
9. Destruction of noradrenergic terminals increases dopamine concentration and reduces dopamine metabolism in the medial prefrontal cortex. Gálosi R; Petykó Z; Kállai V; Tóth A; Ollmann T; Péczely L; Kovács A; Berta B; Lénárd L Behav Brain Res; 2018 May; 344():57-64. PubMed ID: 29454007 [TBL] [Abstract][Full Text] [Related]
10. The dopamine beta-hydroxylase inhibitor nepicastat increases dopamine release and potentiates psychostimulant-induced dopamine release in the prefrontal cortex. Devoto P; Flore G; Saba P; Bini V; Gessa GL Addict Biol; 2014 Jul; 19(4):612-22. PubMed ID: 23289939 [TBL] [Abstract][Full Text] [Related]
11. Systemic and intra-accumbens administration of amphetamine differentially affects cortical acetylcholine release. Arnold HM; Nelson CL; Neigh GN; Sarter M; Bruno JP Neuroscience; 2000; 96(4):675-85. PubMed ID: 10727786 [TBL] [Abstract][Full Text] [Related]
12. Adrenergic hyperactivity and metanephrine excess in the nucleus accumbens after prefrontocortical dopamine depletion. Espejo EF; Miñano J J Neurophysiol; 2001 Mar; 85(3):1270-4. PubMed ID: 11247995 [TBL] [Abstract][Full Text] [Related]
13. Norepinephrine in prelimbic cortex delays extinction of amphetamine-induced conditioned place preference. Latagliata EC; Saccoccio P; Milia C; Puglisi-Allegra S Psychopharmacology (Berl); 2016 Mar; 233(6):973-82. PubMed ID: 26660648 [TBL] [Abstract][Full Text] [Related]
14. Effects of catecholamine uptake blockers in the caudate-putamen and subregions of the medial prefrontal cortex of the rat. Mazei MS; Pluto CP; Kirkbride B; Pehek EA Brain Res; 2002 May; 936(1-2):58-67. PubMed ID: 11988230 [TBL] [Abstract][Full Text] [Related]
15. Netrin-1 receptor-deficient mice show enhanced mesocortical dopamine transmission and blunted behavioural responses to amphetamine. Grant A; Hoops D; Labelle-Dumais C; Prévost M; Rajabi H; Kolb B; Stewart J; Arvanitogiannis A; Flores C Eur J Neurosci; 2007 Dec; 26(11):3215-28. PubMed ID: 18005074 [TBL] [Abstract][Full Text] [Related]
16. The 5-HT Korte SM; Prins J; Van den Bergh FS; Oosting RS; Dupree R; Korte-Bouws GA; Westphal KG; Olivier B; Denys DA; Garland A; Güntürkün O Eur J Pharmacol; 2017 Jan; 794():257-269. PubMed ID: 27866999 [TBL] [Abstract][Full Text] [Related]
17. Dopamine depletion in the medial prefrontal cortex induces sensitized-like behavioral and neurochemical responses to cocaine. Beyer CE; Steketee JD Brain Res; 1999 Jul; 833(2):133-41. PubMed ID: 10375688 [TBL] [Abstract][Full Text] [Related]
18. 5-HT(6) receptor antagonism potentiates the behavioral and neurochemical effects of amphetamine but not cocaine. Frantz KJ; Hansson KJ; Stouffer DG; Parsons LH Neuropharmacology; 2002 Feb; 42(2):170-80. PubMed ID: 11804613 [TBL] [Abstract][Full Text] [Related]
19. Regional extracellular norepinephrine responses to amphetamine and cocaine and effects of clonidine pretreatment. Florin SM; Kuczenski R; Segal DS Brain Res; 1994 Aug; 654(1):53-62. PubMed ID: 7982098 [TBL] [Abstract][Full Text] [Related]
20. Neurochemical evidence that cocaine- and amphetamine-regulated transcript (CART) 55-102 peptide modulates the dopaminergic reward system by decreasing the dopamine release in the mouse nucleus accumbens. Rakovska A; Baranyi M; Windisch K; Petkova-Kirova P; Gagov H; Kalfin R Brain Res Bull; 2017 Sep; 134():246-252. PubMed ID: 28802898 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]